Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa

J S Phillips1, S E M Jones

  • 1Department of Otolaryngology, Norfolk and Norwich University Hospital, Colney Lane, Norwich, Norfolk, UK, NR4 7UY. john.phillips@mac.com

Abstract

Insights

This review found no evidence for hyperbaric oxygen therapy in treating malignant otitis externa. Further research is needed to compare this treatment with standard therapies like antibiotics and surgery.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Hyperbaric Medicine

Background:

  • Malignant otitis externa is a severe, potentially fatal infection affecting the ear canal, soft tissue, and bone.
  • Complications can include cranial nerve involvement, particularly the facial nerve and jugular foramen contents.
  • This condition is rare, primarily affecting the elderly and individuals with diabetes.

Purpose of the Study:

  • To evaluate the effectiveness of hyperbaric oxygen therapy as an adjunct treatment for malignant otitis externa.

Main Methods:

  • Searched CENTRAL, MEDLINE, and EMBASE databases up to April 2004.
  • Included randomized controlled trials involving adults receiving hyperbaric oxygen therapy for malignant otitis externa.

Main Results:

  • No randomized controlled trials were identified that investigated hyperbaric oxygen therapy for malignant otitis externa.
  • Due to the lack of data, no results could be presented.

Conclusions:

  • There is no clear evidence supporting the efficacy of hyperbaric oxygen therapy compared to antibiotics and/or surgery for malignant otitis externa.
  • Data comparing complication rates between treatment modalities were unavailable.
  • Further research is necessary to establish the role of hyperbaric oxygen therapy.